SCHEMBL7960074

SCHEMBL7960074

NNC(=O)NNCCCN1CCC(O)(c2ccc(Cl)cc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.62
CCR1 P32246 12/20 0.59
ADRA1A P35348 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960233 0.89 CCR1 (0.54) DRD2CCR1ADRA1A
SCHEMBL7949619 0.89 DRD2 (0.53) DRD2CCR1ADRA1A
SCHEMBL7949042 0.88 CCR1 (0.52) DRD2CCR1
SCHEMBL7957164 0.87 DRD2 (0.56) DRD2CCR1
SCHEMBL7957456 0.86 CCR1 (0.56) DRD2CCR1ADRA1A
SCHEMBL7963903 0.85 DRD2 (0.50) DRD2CCR1
SCHEMBL7961470 0.83 DRD2 (0.49) DRD2CCR1
SCHEMBL7964042 0.83 DRD2 (0.46) DRD2CCR1
SCHEMBL8568579 0.83 OPRM1 (0.58) DRD2CCR1
SCHEMBL7963515 0.83 CCR1 (0.58) DRD2CCR1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed